Table 2.
Adverse effects | HIVEC n (%) | BCG n (%) | P |
---|---|---|---|
Nil | 19 (86.4) | 4 (13.8) | 0.001 |
Grade I | 2 (9.1) | 6 (20.7) | 0.331 |
Grade II | 0 (0) | 13 (44.8) | Significant |
Grade III | 1 (4.5) | 6 (20.7) | 0.143 |
HIVEC: Hyperthermic Intra-VEsical Chemotherapy, BCG: Bacillus Calmette-Guerin